🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Enovis Corporation

ENOV Healthcare
$18.18 $-0.48 (-2.57%)
Market Cap: $1.05 B
Gurus Holding
6
Popularity Rank
#1460
% of Shares Held
2.45%
Net Activity (Q2 2026)
+$5.38 M

Guru Ownership Trend

Guru Analysis for Enovis Corporation (ENOV)

Enovis Corporation (ENOV), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $25.7 M.

Top institutional holders include Chuck Royce and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $5.38 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 108.0%. Conversely, Paul Tudor Jones reduced exposure by 83.1%.

Key Holders

Top 5 by Value

$13.71 M
$12.23 M
$1.6 M
$916,141
$520,957

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$7.95 M
Total Buy Value
New Buys 0
Additions 4
-$2.56 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for Enovis Corporation (ENOV)

Major holders include Chuck Royce ($13.71 M), Cliff Asness ($12.23 M), Ray Dalio ($1.6 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.41 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.38 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ENOV. The total reported sell value was $2.56 M.

Yes, 0 managers opened new positions in ENOV, and 4 increased their existing holdings. The total reported buy value was $7.95 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.11% Add 8.4% 662,183 $13.71 M Q2 2026
0.00% Add 108.0% 590,647 $12.23 M Q2 2026
0.01% Add 50.5% 77,088 $1.6 M Q2 2026
0.05% 44,258 $916,141 Q2 2026
0.00% Reduce -83.1% 25,167 $520,957 Q2 2026
0.00% Add 1.3% 14,243 $294,830 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form